Jennifer Burkmar, MD
Family Medicine · Panama City, FLNPI 1437437357
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $223 of the $285 with a category attached, or 78.4%. 7 manufacturers reported payments, led by Amgen at 40.5% of the total. Reporting peaked in 2019 at $129 and has fallen 72.0% since, to $36 in 2021. That places this record below the midpoint for family medicine clinicians in FL, where the typical reported total is $424.
Across 15 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$115
- AbbVie$61
- Novo Nordisk$42
- Lilly USA, LLC$19
- Xeris Pharmaceuticals, Inc.$19
- Takeda Pharmaceuticals U.S.A., Inc.$15
- plus $13 from 1 others
What the payments were for
- Food & beverage$22378%
- Education$6122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 6 | $115 |
| AbbVie | 2 | $61 |
| Novo Nordisk | 3 | $42 |
| Lilly USA, LLC | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Gilead | 1 | $13 |
How this compares
$285 in reported general payments places this provider in the 40th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 114 | $28,570 |
| NuedextaDextromethorphan Hbr/Quinidine | 15 | $11,191 |
| XareltoRivaroxaban | 24 | $6,806 |
| JanuviaSitagliptin Phosphate | 19 | $4,797 |
| Budesonide | 22 | $4,785 |
| Atorvastatin Calcium | 161 | $3,738 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $3,455 |
| Divalproex Sodium | 27 | $2,284 |
| Methenamine Hippurate | 22 | $1,935 |
| Memantine Hcl | 21 | $1,873 |
| Levetiracetam | 37 | $1,872 |
| Montelukast Sodium | 75 | $1,737 |
| Fentanyl | 20 | $1,675 |
| Tamsulosin Hcl | 89 | $1,552 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 46 | $1,391 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Panama City
- Roman NationPanama City$59K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.